UniProtKB/Swiss-Prot Q9UPN9: Variant p.Ile840Thr

E3 ubiquitin-protein ligase TRIM33
Gene: TRIM33
Feedback?

Variant information Variant position:

840 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Isoleucine (I) to Threonine (T) at position 840 (I840T, p.Ile840Thr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and hydrophobic (I) to medium size and polar (T) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs6537825 [ dbSNP | Ensembl ]

Sequence information Variant position:

840 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

1127 The length of the canonical sequence.
Location on the sequence:

TNLHLESELDALASLENHVK I EPADMNESCKQSGLSSLVNG The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         T--NLHLESELDALASLENHVKIEP--ADMNESCKQSGLSSLVNG

Mouse                         T--NLHLESELDTLTGLENHVKTEP--TDISESCKQSGLSN

Xenopus laevis                T--NVHLETDLESLAALENNVKTEP--NNTSQSCRQSSHVS

Zebrafish                     ILGSVSTGSVQDILRTLGENVKSEPQSDNLSSCTNPNSRAT

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 1127	E3 ubiquitin-protein ligase TRIM33

Literature citations
TIF1gamma, a novel member of the transcriptional intermediary factor 1 family.
Venturini L.; You J.; Stadler M.; Galien R.; Lallemand V.; Koken M.H.M.; Mattei M.-G.; Ganser A.; Chambon P.; Losson R.; De The H.;
Oncogene 18:1209-1217(1999)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA); FUNCTION; SUBUNIT; VARIANT THR-840; The tripartite motif family identifies cell compartments.
Reymond A.; Meroni G.; Fantozzi A.; Merla G.; Cairo S.; Luzi L.; Riganelli D.; Zanaria E.; Messali S.; Cainarca S.; Guffanti A.; Minucci S.; Pelicci P.G.; Ballabio A.;
EMBO J. 20:2140-2151(2001)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA AND BETA); VARIANT THR-840; Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.
Kikuno R.; Nagase T.; Ishikawa K.; Hirosawa M.; Miyajima N.; Tanaka A.; Kotani H.; Nomura N.; Ohara O.;
DNA Res. 6:197-205(1999)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA); VARIANT THR-840; The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas.
Klugbauer S.; Rabes H.M.;
Oncogene 18:4388-4393(1999)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 76-1127 (ISOFORMS ALPHA AND BETA); CHROMOSOMAL TRANSLOCATION WITH RET; VARIANT THR-840;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.